awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38397403-2A773048-EA94-4F65-B4DE-BE97BEE178D7
Q38397403-2A773048-EA94-4F65-B4DE-BE97BEE178D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38397403-2A773048-EA94-4F65-B4DE-BE97BEE178D7
Giving rituximab in patients with occult or resolved hepatitis B virus infection: are the current guidelines good enough?
P2860
Q38397403-2A773048-EA94-4F65-B4DE-BE97BEE178D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38397403-2A773048-EA94-4F65-B4DE-BE97BEE178D7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
47d840628d3bb33f63f581333093ff4b41747803
P2860
Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.